Remdesivir Completed Phase 3 Trials for COVID-19 Pneumonia / Coronavirus Disease 2019 (COVID‑19) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT04409262 | A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia |